How should nurses handle conflicts of interest related to pharmaceutical sponsorship or device incentives?

• A. Disclose potential conflicts, recuse from decision-making if necessary, and adhere to institutional policies and professional standards.
• B. Recuse from decision-making if necessary and disclose conflicts when appropriate, following professional standards.
• C. Ignore conflicts to avoid slowing patient care.
• D. Promote sponsors' products in patient education.

Answer: (A)

Handling conflicts of interest when sponsorship or device incentives are involved means being transparent and putting patient welfare first. Disclosing potential conflicts to the right people lets the care team see where influence might come from and assess whether it could bias decisions. If there’s a real risk of bias affecting patient care, stepping back from the decision-making process—recusing yourself—helps keep choices focused on what’s best for the patient rather than any sponsor interest. Following both institutional policies and professional standards provides a clear, consistent framework for how to disclose, manage, and document conflicts. Together, these steps protect patient trust, preserve professional integrity, and align practice with ethical obligations like beneficence, nonmaleficence, autonomy, and justice.

Ignoring conflicts is inappropriate because it can bias care and erode trust. Promoting a sponsor’s products in patient education compromises patient welfare and professional ethics. Simply recusing or disclosing without the backing of established institutional policies may leave gaps in accountability and guidance.